842 related articles for article (PubMed ID: 15313816)
21. Basal cell carcinoma with mixed histology: a possible pathogenesis for recurrent skin cancer.
Cohen PR; Schulze KE; Nelson BR
Dermatol Surg; 2006 Apr; 32(4):542-51. PubMed ID: 16681663
[TBL] [Abstract][Full Text] [Related]
22. Adamantinoid basal cell carcinoma: a predictor of more-aggressive clinical behavior.
Berk DR; Ball Arefiev KL; Gladstone HB
Dermatol Surg; 2012 Aug; 38(8):1346-50. PubMed ID: 22551358
[TBL] [Abstract][Full Text] [Related]
23. Recurrence rates of aggressive histologic types of basal cell carcinoma after treatment with electrodesiccation and curettage alone.
Blixt E; Nelsen D; Stratman E
Dermatol Surg; 2013 May; 39(5):719-25. PubMed ID: 23379543
[TBL] [Abstract][Full Text] [Related]
24. An assessment of incomplete facial Basal cell carcinoma excision.
Shah SA; Obaidullah ; Fahimullah
J Coll Physicians Surg Pak; 2005 Mar; 15(3):149-51. PubMed ID: 15808092
[TBL] [Abstract][Full Text] [Related]
25. Basal cell carcinoma in a series of renal transplant recipients: epidemiology and clinicopathologic features.
Mertz KD; Proske D; Kettelhack N; Kegel C; Keusch G; Schwarz A; Ambühl PM; Pfaltz M; Kempf W
Int J Dermatol; 2010 Apr; 49(4):385-9. PubMed ID: 20465691
[TBL] [Abstract][Full Text] [Related]
26. Periocular basal cell carcinoma: 5-year outcome following Slow Mohs surgery with formalin-fixed paraffin-embedded sections and delayed closure.
Morris DS; Elzaridi E; Clarke L; Dickinson AJ; Lawrence CM
Br J Ophthalmol; 2009 Apr; 93(4):474-6. PubMed ID: 19060015
[TBL] [Abstract][Full Text] [Related]
27. Dermatofibrosarcoma protuberans: a report on 29 patients treated by Mohs micrographic surgery with long-term follow-up and review of the literature.
Snow SN; Gordon EM; Larson PO; Bagheri MM; Bentz ML; Sable DB
Cancer; 2004 Jul; 101(1):28-38. PubMed ID: 15221986
[TBL] [Abstract][Full Text] [Related]
28. Cutaneous lip tumours treated with Mohs micrographic surgery: clinical features and surgical outcome.
Leibovitch I; Huilgol SC; Selva D; Paver R; Richards S
Br J Dermatol; 2005 Dec; 153(6):1147-52. PubMed ID: 16307650
[TBL] [Abstract][Full Text] [Related]
29. Residual skin cancer after preoperative biopsy: evaluation by Mohs micrographic surgery.
Alcalay J; Alkalay R; Hazaz B
Int J Dermatol; 2004 Jun; 43(6):456-8. PubMed ID: 15186232
[TBL] [Abstract][Full Text] [Related]
30. Dermatofibrosarcoma protuberans: wide local excision vs. Mohs micrographic surgery.
Paradisi A; Abeni D; Rusciani A; Cigna E; Wolter M; Scuderi N; Rusciani L; Kaufmann R; Podda M
Cancer Treat Rev; 2008 Dec; 34(8):728-36. PubMed ID: 18684568
[TBL] [Abstract][Full Text] [Related]
31. Differences in age and body site distribution of the histological subtypes of basal cell carcinoma. A possible indicator of differing causes.
McCormack CJ; Kelly JW; Dorevitch AP
Arch Dermatol; 1997 May; 133(5):593-6. PubMed ID: 9158412
[TBL] [Abstract][Full Text] [Related]
32. Increased incidence and recurrence rates of nonmelanoma skin cancer in patients with non-Hodgkin lymphoma: a Rochester Epidemiology Project population-based study in Minnesota.
Brewer JD; Shanafelt TD; Khezri F; Sosa Seda IM; Zubair AS; Baum CL; Arpey CJ; Cerhan JR; Call TG; Roenigk RK; Smith CY; Weaver AL; Otley CC
J Am Acad Dermatol; 2015 Feb; 72(2):302-9. PubMed ID: 25479909
[TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness of Mohs Micrographic Surgery vs Surgical Excision for Basal Cell Carcinoma of the Face.
Essers BA; Dirksen CD; Nieman FH; Smeets NW; Krekels GA; Prins MH; Neumann HA
Arch Dermatol; 2006 Feb; 142(2):187-94. PubMed ID: 16490846
[TBL] [Abstract][Full Text] [Related]
34. Basal cell carcinoma of the head region: therapeutical results of 350 lesions treated with Mohs micrographic surgery.
Veronese F; Farinelli P; Zavattaro E; Zuccoli R; Bonvini D; Leigheb G; Colombo E
J Eur Acad Dermatol Venereol; 2012 Jul; 26(7):838-43. PubMed ID: 21707774
[TBL] [Abstract][Full Text] [Related]
35. Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia I. Experience over 10 years.
Leibovitch I; Huilgol SC; Selva D; Hill D; Richards S; Paver R
J Am Acad Dermatol; 2005 Aug; 53(2):253-60. PubMed ID: 16021120
[TBL] [Abstract][Full Text] [Related]
36. [Low 5-year recurrence rate after surgical excision of 126 basal cell carcinomas with frozen section analysis upon indication].
van der Meer GT; Willemse F; Marck KW
Ned Tijdschr Geneeskd; 2001 Jul; 145(29):1409-13. PubMed ID: 11494691
[TBL] [Abstract][Full Text] [Related]
37. Linear basal cell carcinoma: a distinct clinical entity in the periocular region.
Mavrikakis I; Malhotra R; Barlow R; Huilgol SC; Selva D
Ophthalmology; 2006 Feb; 113(2):338-42. PubMed ID: 16406534
[TBL] [Abstract][Full Text] [Related]
38. Longitudinal diminution of tumor size for basal cell carcinoma suggests shifting referral patterns for Mohs surgery.
Kaplan AL; Weitzul SB; Taylor RS
Dermatol Surg; 2008 Jan; 34(1):15-9. PubMed ID: 18053056
[TBL] [Abstract][Full Text] [Related]
39. Basal cell carcinoma on the trunk is associated with excessive sun exposure.
Neale RE; Davis M; Pandeya N; Whiteman DC; Green AC
J Am Acad Dermatol; 2007 Mar; 56(3):380-6. PubMed ID: 17097387
[TBL] [Abstract][Full Text] [Related]
40. Low recurrence rate of head and neck basal cell carcinoma treated with Mohs micrographic surgery: A retrospective study of 1021 cases.
Kuiper EM; van den Berge BA; Spoo JR; Kuiper J; Terra JB
Clin Otolaryngol; 2018 Oct; 43(5):1321-1327. PubMed ID: 29953746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
